Groundbreaking Study Sheds Light on South Asian IBD Patients
A new study published in the Journal of Crohn’s and Colitis reveals that South Asian patients with Inflammatory Bowel Disease (IBD) are more likely to be diagnosed at a younger age and have a different form of the disease compared to their white counterparts. This research, funded by Bowel Research UK and the National Institute of Health Research Imperial Biomedical Research Centre, is the largest of its kind focusing on South Asian IBD patients in the UK.
IBD is an umbrella term for diseases causing inflammation in the digestive tract, including Ulcerative Colitis (UC) and Crohn’s Disease (CD). UC typically affects the large intestine, while CD can affect any part of the digestive tract. Both conditions are characterised by symptoms such as diarrhoea, abdominal pain, and a sudden urge to use the bathroom. Medication or surgery is often required to manage these symptoms.
The study analysed data from over 30,000 patients and found that South Asian patients had a higher prevalence of Ulcerative Colitis compared to their white counterparts (57% vs. 45%). South Asian patients were also diagnosed with IBD, on average, two years younger. The research further highlighted that IBD was more common among South Asian men than women, while in the white population, the disease affected both genders more equally.
IBD is a prevalent condition in the UK, with around 300,000 people currently living with it, many of whom are diagnosed before the age of 35. Dr. Sharmili Balarajah, a researcher from Bowel Research UK and doctoral student at Imperial College London, highlighted the significance of these findings. “Our current understanding of IBD has mainly been shaped by studies focused on white populations. This groundbreaking research reveals distinct variations in IBD among ethnic groups, particularly South Asians. By understanding these differences, we can develop more personalised treatment approaches that cater to the specific needs of these patients,” she explained.
In addition to demographic differences, the study found that the disease manifests differently across ethnicities. South Asian patients were more likely to have the large bowel affected and less likely to experience narrowing of the bowel (stricturing) in Crohn’s Disease. They were also more likely to have extensive large bowel inflammation in Ulcerative Colitis compared to white patients. These differences highlight the importance of considering ethnicity when diagnosing and treating IBD.
Despite these differences, the research indicated that South Asian and white patients received similar levels of care. Lindsay Easton, CEO of Bowel Research UK, emphasised the importance of this research, stating, “IBD is a debilitating disease that significantly impacts individuals, particularly those diagnosed in their 20s and 30s. There is still much to learn about the causes of IBD, and this research is a step toward understanding how to tailor care for different ethnic groups.”
This study marks a significant step forward in understanding how ethnicity can influence the onset and progression of IBD. With further research, it could pave the way for more personalised treatment strategies, improving outcomes for diverse patient populations. The findings will help medical professionals better understand the disease’s behaviour in South Asian patients and other ethnic groups, leading to improved treatment options in the future.